These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 231062)

  • 41. Rapid assay of insulin in portosplenic blood for insulinoma.
    Yao CZ; Zeng XJ; Niu ZP
    Chin Med J (Engl); 1984 Jan; 97(1):57-60. PubMed ID: 6329612
    [No Abstract]   [Full Text] [Related]  

  • 42. Diagnostic interpretation of the intravenous tolbutamide test for insulinoma.
    McMahon MM; O'Brien PC; Service FJ
    Mayo Clin Proc; 1989 Dec; 64(12):1481-8. PubMed ID: 2557494
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glucose-induced GIP levels in patients with insulinoma.
    Tamburrano G; Lala A; Mauceri M; Leonetti F; Andreani D
    Horm Metab Res; 1984 Dec; 16 Suppl 1():200-3. PubMed ID: 6099816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Aggravation of hypoglycemia in insulinoma patients by the long-acting somatostatin analogue octreotide (Sandostatin).
    Stehouwer CD; Lems WF; Fischer HR; Hackeng WH; Naafs MA
    Acta Endocrinol (Copenh); 1989 Jul; 121(1):34-40. PubMed ID: 2545062
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The use of glucagon challenge tests in the diagnostic evaluation of hypoglycemia due to hepatoma and insulinoma.
    Pun KK; Young RT; Wang C; Tam CF; Ho PW
    J Clin Endocrinol Metab; 1988 Sep; 67(3):546-50. PubMed ID: 2842361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Different serum insulin patterns in portal, hepatic and peripheral venous blood in two cases of insuloma.
    Erwald R; Hed R; Marions O; Nandorf R; Nygren A; Röjdmark S; Sundblad L; Wiechel KL
    Acta Med Scand; 1972 Mar; 191(3):171-5. PubMed ID: 4338255
    [No Abstract]   [Full Text] [Related]  

  • 47. Endocrine responses of type 1 (insulin-dependent) diabetic patients following successful pancreas transplantation.
    Pozza G; Traeger J; Dubernard JM; Secchi A; Pontiroli AE; Bosi E; Malik MC; Ruitton A; Blanc N
    Diabetologia; 1983 Apr; 24(4):244-8. PubMed ID: 6134651
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunoreactive insulin in portal and hepatic venous blood in patients with insuloma.
    Eriksson M; Erwald R; Hed R; Nygren A; Patricny J; Röjdmark S; Sundblad L; Wiechel KL
    Acta Med Scand; 1976; 200(3):145-9. PubMed ID: 184688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of a long acting glucagon selective somatostatin analogue on plasma glucose, insulin and glucagon levels in the anaesthetized rat during arginine infusion.
    Lien E; Sarantakis D
    Diabetologia; 1979 Jul; 17(1):59-64. PubMed ID: 467854
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Biological diagnosis of insulinomas. Determination of the insulin/modified glucose ratio].
    Lalau JD; Gheerbrant JD; Arlot S; Maurel G; Moullart V; Quichaud J
    Presse Med; 1984 Jan; 13(3):170. PubMed ID: 6320158
    [No Abstract]   [Full Text] [Related]  

  • 51. Lack of effect of calcium infusion on blood glucose and plasma insulin levels in patients with insulinoma.
    De Palo C; Sicolo N; Vettor R; Federspil G
    J Clin Endocrinol Metab; 1981 Apr; 52(4):804-6. PubMed ID: 6259196
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Progress report. Diagnosis of insulinoma.
    Marks V
    Gut; 1971 Oct; 12(10):835-43. PubMed ID: 4330782
    [No Abstract]   [Full Text] [Related]  

  • 53. Somatostatin inhibition of insulin secretion in insulin-producing tumors.
    Scuro LA; Lo Cascio V; Adami S; Galvanini G; Bianchi I; Cominacini L; Corgnati A
    Metabolism; 1976 Jun; 25(6):603-9. PubMed ID: 178978
    [No Abstract]   [Full Text] [Related]  

  • 54. Role of insulin and glucose in the induction of hypoaminoacidemia in man: studies in normal, juvenile diabetic, and insuloma patients.
    Adibi SA; Morse EL; Amin PM
    J Lab Clin Med; 1975 Sep; 86(3):395-409. PubMed ID: 168278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Studies on the mechanism of somatostatin action on insulin release in man. II. Comparison of the effects of somatostatin on insulin release induced by glucose, glucagon and tolbutamide.
    Efendić S; Luft R; Claro A
    Acta Endocrinol (Copenh); 1976 Apr; 81(4):743-52. PubMed ID: 946564
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of somatostatin and a glucagon-specific analog on glucose homeostasis during arginine infusion.
    Lien EL
    Metabolism; 1978 Sep; 27(9):1095-100. PubMed ID: 682972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Lack of suppression of insulin secretion by exercise in patients with insulinoma.
    Järhult J; Ericsson M; Holst J; Ingemansson S
    Clin Endocrinol (Oxf); 1981 Oct; 15(4):391-4. PubMed ID: 6274547
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Gastrointestinal/pancreatic hormone concentrations in the portal venous system of nine patients with organic hyperinsulinism.
    Glaser B; Valtysson G; Fajans SS; Vinik AI; Cho K; Thompson N
    Metabolism; 1981 Oct; 30(10):1001-10. PubMed ID: 6116152
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The metabolic effects of chronic hyperglucagonaemia.
    Nankervis A; Proietto J; Ng KW; Alford FP; Larkins R
    Clin Endocrinol (Oxf); 1981 Oct; 15(4):325-33. PubMed ID: 6274544
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Atypical case of insulinoma (author's transl)].
    Lucke C; Grögler F; Mitzkat HJ
    Med Klin; 1974 Sep; 69(36):1456-9. PubMed ID: 4373641
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.